Citigroup Inc (C) News 47.25 $C Could A New Tax on Banks

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Citigroup Inc (C) News 47.25 $C

Could A New Tax on Banks Destroy Your Dividends?
Jessica Alling, The Motley Fool - Motley Fool - 46 mins ago
With a new tax proposal spreading across Capitol Hill, Wall Street's banks, both big and small, are standing together in protest. But the impact of the tax would spread much further than the banks' financial statements -- all the way through Main...

1 Shocking Stat About AIG, Bank of America, and National Bank of Greece
Matt Koppenheffer and David Hanson, The Motley Fool - Motley Fool - 2 hrs 46 mins ago
In this segment of Monday's Where the Money Is , Motley Fool banking analysts Matt Koppenheffer and David Hanson do their worst to stump each other on this week's Stock Quiz. The questions focus on just how bad AIG 's combined ratio got in the...

Most active New York Stock Exchange-traded stocks
AP - Fri Mar 28, 5:02PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:

Final Glance: Banks companies
AP - Fri Mar 28, 5:02PM CDT
NEW YORK (AP) — Shares of some top banks companies were mixed at the close of trading:

25 Banks Went to the Head of the Class This Week
Eric Volkman, The Motley Fool - Motley Fool - Fri Mar 28, 4:32PM CDT
In the banking sector, this week was dominated by Wednesday's release of the Comprehensive Capital Analysis and Review (CCAR, for those who want to conserve their oxygen). This was the second part of the Federal Reserve's stress tests for this year,...

BB&T to Further Boost Insurance Biz - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 2:20PM CDT
BB&T's subsidiary, BB&T Insurance Services, announced the acquisition of Woodbury & Co. The deal will increase the company's footprint in North and South Carolina.

Citigroup to Redeem $2B TruPS - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 1:25PM CDT
On Thursday, Citigroup Inc. (C) announced the redemption of trust preferred securities (TruPS) worth $2 billion.

Is Citigroup Plan Rejection Trouble for These ETFs? - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Fri Mar 28, 1:00PM CDT
Investors should watch these ETFs for further weakness in the days ahead and take advantage of the lower price resulting from Citigroup.

Midday Glance: Banks companies
AP - Fri Mar 28, 12:32PM CDT
NEW YORK (AP) — Shares of some top banks companies are mixed at 1 p.m.:


World stocks gain on US data, China stimulus hopes
The Associated Press - AP - Fri Mar 28, 11:56AM CDT
LONDON (AP) — World stock markets pushed higher Friday after a measure of U.S. consumer spending rose and expectations grew that China will move to counter its economic slowdown.

Active Equities Watch List -- Research on Bank of America, Wells Fargo, Citigroup, and JPMorgan Chase
PR Newswire - Fri Mar 28, 9:42AM CDT
The trading session on Thursday, March 27, 2014 ended on a negative note as the Dow Jones Industrial Average finished at 16,264.23, down 0.03% and the NASDAQ Composite closed at 4,151.23, down 0.54%. The S&P 500 finished the session 0.19% lower at 1,849.04. The losses were broad based as seven out of ten sectors ended the session in negative. During the session, Information Technology, Financials, and Consumer Discretionary sectors exerted a drag, while some positive momentum was observed in the Telecommunication Services, Energy, and Utilities sectors. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Bank of America Corp. (NYSE: BAC), Wells Fargo & Co. (NYSE: WFC), Citigroup Inc. (NYSE: C) and JPMorgan Chase & Co. (NYSE: JPM). Free technical research on BAC, WFC, C and JPM can be downloaded upon signing up at:

Early Glance: Banks companies
AP - Fri Mar 28, 9:22AM CDT
NEW YORK (AP) — Shares of some top banks companies are up at 10 a.m.:

Stock Market News for March 28, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 9:06AM CDT
Benchmarks ended lower on Thursday as investors feared sooner-than-expected rate hikes

Citigroup's Business Model Is 'Not Sustainable,' Says Societe Generale
at The Street - Fri Mar 28, 8:55AM CDT
With its capital plans rejected twice in three years, it's time for Citi to radically simplify its operations, according to Societe Generale.

Will This Downgrade Hurt Citigroup (C) Today?
at The Street - Fri Mar 28, 8:03AM CDT
Societe Generale downgraded Citigroup (C) to "hold" from "buy" and set a $52 target price. The firm noted the company is returning less capital to investors.

Citigroup (C) Crumbles: Stock Falls by 5.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 7:59AM CDT
The shares of Citigroup fell by over 5 % on the day. This breaks the recent trend of the company, as the stock is now trading within the volatile price range of $46.9 to $50.3 in the past one-month time frame. This slump shouldn’t be too much of a surprise to investors, as the Banking company has seen 9 negative revisions in the past few weeks.

Downgrade Alert for Citigroup (C)
Comtex SmarTrend(R) - Fri Mar 28, 7:02AM CDT
Citigroup (NYSE:C) was downgraded from Buy to Hold at Societe Generale today. The stock closed yesterday at $47.45 on volume of 112.5 million shares, above average daily volume of 25.6 million. Citigroup has overhead space with shares priced $47.45, or 17.7% below the average consensus analyst price target of $57.64. The stock should find initial resistance at its 50-day moving average (MA) of $49.15 and further resistance at its 200-day MA of $50.23.

What to Make of the Very Eventful Week for Bank of America Corp. and Citigroup Inc.
Patrick Morris, The Motley Fool - Motley Fool - Fri Mar 28, 7:00AM CDT
This week the paths of Bank of America and Citigroup  went in opposite directions. Investors -- like the banks -- are now asking, what comes next? Source: Flickr / Chris Parker2012. When the Federal Reserve announced the results of its...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

M&A Source's 2026 Conference Tackles Deal-Making Drama

Updated Category News Views 130

High Stakes and Deep Insights Await in Houston Cracking the nut of lower-middle market transactions ain’t a walk in the park. M&A Source®'s Fall 2026 Conference is gearing up to address the very dramas that lurk behind the scenes. Kicking off November 2-4 at the opulent JW Marriott in Houston, Texas, the event is looking to assemble a heavyweight lineup of...

Continue Reading
Endava Faces Class Action: Investors Eye Their Next Move

Updated Category News Views 0

A Mess That Investors Can't Ignore If you're holding onto Endava plc shares, you've probably felt that gut-punch lately. Yeah, things are getting heated with a class action lawsuit alleging the company played fast and loose with its accounting practices. The complaint's about some shady dealings that may have thrown off investors' perceptions. The Core Allegations This...

Continue Reading
Astellas and Audax Forge $1.34B Immuno-Oncology Deal

Updated Category News Views 36

Big Moves in Immuno-Oncology: Astellas' Latest Bet You hear 'immuno-oncology,' you think breakthrough, right? Well, friends, that's what Astellas and Audax Biosciences are shooting for with their fresh handshake over DAX-044. On October 27, 2026, in Tokyo and Melbourne, the two outfits announced they're joining forces to bring this novel immunotherapy to the table. It's...

Continue Reading
OneQode & AdaniConneX Forge AI Path in India

Updated Category News Views 17

A Major Step Forward in AI Infrastructure When two heavyweights clash, you better believe folks are paying attention. OneQode’s deal with AdaniConneX is like a shot across the bow in the AI infrastructure arena. They’re not just dipping a toe in India’s tech waters; they’re diving headfirst with 14 MW of data center muscle right there in Siruseri Sipcot, Chennai....

Continue Reading
Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 48

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Brightstar's Cash Pop Shakes Up Illinois Lottery Scene

Updated Category News Views 63

A New Twist in Illinois: Cash Pop's Arrival Here's something fresh off the press: the Illinois Lottery is now on the ride with Brightstar's Cash Pop. This patented game isn't just another number pick—it's an engaging draw-based game featuring hourly draws with price tags of $1, $2, $5, and $10. It's like clockwork, and trust me, it's more than just the usual spin....

Continue Reading
Etisalat Surges: Net Profit Soars 46% Amid Growth

Updated Category News Views 91

Etisalat's Stellar Performance: A Deeper Dive When a company like Etisalat drops news of a whopping 46% increase in net profit year-over-year, you sit up and pay attention. Those numbers aren’t just a flash in the pan; they're the result of some serious strategic maneuvers and ripe market conditions. Etisalat isn't resting on its laurels, and their latest financials...

Continue Reading
Amgen Declares Q4 Dividend Amidst Broad Horizons

Updated Category News Views 16

Amgen's Steady Dividend: A Testament to Stability Diving into the mess that is today's biotech market, Amgen (NASDAQ:AMGN) stands out like a beacon of stability with its recent dividend announcement. The Board's decision to dole out a $2.52 per share dividend for the fourth quarter of 2026 showcases confidence amidst both promising ventures and looming uncertainties....

Continue Reading
2026 World Laureates Forum Drives Science Forward

Updated Category News Views 78

A Meeting of Great Minds in Shanghai Alright, listen up. Shanghai's gearing up to be the nerve center for the 2026 World Laureates Forum (WLF), and it's seething with potential. This ain't your regular science fair; it's a lion's den of brainpower set to crack open the future of science and tech. With the heavy-hitters like Nobel and Turing laureates on the docket, you're...

Continue Reading
Mercado González Opens, Integrates Mexican Culture

Updated Category News Views 27

Dive into Mercado González's Cultural Opening Over in La Habra, Northgate González Market has just flung open the doors to its latest masterpiece: Mercado González. Picture this, a place where the mundanity of grocery shopping melds with a vibrant fiesta of Mexican cuisine, artisanry, and cultural vibes. They transformed an older store into something that commands not...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Exelon's Earnings: Insights and Future Potential

Updated Category News Views 142

Understanding Exelon's Upcoming Earnings Report Exelon Corporation (NASDAQ: EXC) is preparing to reveal its quarterly earnings in the near future. Investors are keenly awaiting the results, as they want insights into the company’s performance and projections for the following period. Analysts predict that Exelon will report an earnings per share (EPS) of $0.39,...

Continue Reading
Vallourec Invites Warrant Holders to General Meeting

Updated Category News Views 157

Vallourec Invites Warrant Holders to General Meeting Vallourec has announced a significant upcoming event for its warrant holders, also known as BSA. This meeting is set to take place soon, providing an opportunity for holders to engage with the company's future decisions. Details of the Meeting The general meeting will occur at the Vallourec headquarters, where the...

Continue Reading
Investigation Initiated for Molina Healthcare Investors Following Financial Reports

Updated Category News Views 246

Pomerantz LLP Begins Investigation on Behalf of Molina Investors Pomerantz LLP has embarked on an investigation focusing on the interests of investors in Molina Healthcare, Inc. (NYSE: MOH). This inquiry aims to ascertain whether Molina and certain executives may have been involved in any unlawful activities related to securities fraud. Key Financial Findings and Investor...

Continue Reading
How SymphonyAI's Insights Drive E-commerce Growth in Grocery

Updated Category News Views 159

Unlocking E-commerce Potential in Grocery Retail In a transformative announcement, SymphonyAI, a leader in predictive and generative AI SaaS products for enterprises, has unveiled groundbreaking insights from its annual grocery e-commerce study. This research indicates a noteworthy 8% growth opportunity for retailers leveraging AI-driven strategies in their connected...

Continue Reading
Exploring the Impact of Honda and Nissan's Potential Merger

Updated Category News Views 408

Honda and Nissan's Strategic Talks Honda (NYSE:HMC) and Nissan (OTC:NSANY) have entered discussions that may lead to a potential merger, a significant move reflecting the shifting landscape of Japan's automotive industry. As these two giants explore deeper ties, it marks a notable strategy to face the competition posed by Tesla and various Chinese car manufacturers....

Continue Reading